Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium

Tissue Engineering - Part A

Volumn 24, Issue 1-2, 2018, Pages 57-67

  Monaghan, Michael G ^a,b,c   Holeiter, Monika ^a,b   Brauchle, Eva ^a,b   Layland, Shannon L ^a,b   Lu, Yan ^d   Deb, Arjun ^d   Pandit, Abhay ^e   Nsair, Ali ^d   Schenke Layland, Katja ^a,b,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

cardiac infarct; collagen; elastin; Heart

Indexed keywords

ANIMALS; COLLAGEN; CROSSLINKING; ELASTIN; GLYCOPROTEINS; HEART; HYDROGELS; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; RNA; TISSUE;

CARDIAC INFARCT; EXTRACELLULAR MATRICES; HISTOLOGICAL ANALYSIS; HYALURONIC ACID HYDROGELS; INJECTABLE BIOMATERIALS; POLYETHYLENE GLYCOL DIACRYLATE; RAMAN MICROSPECTROSCOPY; SIGNIFICANT DETERIORATIONS;

HYALURONIC ACID;

COLLAGEN TYPE 1; ELASTIN; HYALURONIC ACID; MACROGOL; MICRORNA; MICRORNA 239B; MICRORNA 29B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN FIBER; CONTROLLED STUDY; DETERIORATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HISTOLOGY; HYDROGEL; MOUSE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; VASCULARIZATION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CHEMISTRY; CYTOLOGY; ECHOCARDIOGRAPHY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ECHOCARDIOGRAPHY; HYALURONIC ACID; HYDROGELS; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; SPECTRUM ANALYSIS, RAMAN;

EID: 85040606690     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2016.0527     Document Type: Article

References (39)

1. WHO Fact Sheet No. 310. Available at www.who.int/mediacentre/factsheets/fs310/en/(last accessed May 2014).
2. Steg, P.G., James, S.K., Atar, D., Badano, L.P., Lundqvist, C.B., Borger, M.A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A.H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M.J., Mahaffey, K.W., Valgimigli, M., van't Hof, A., Widimsky, P., Zahger, D., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z ? ., Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Hasdai, D., Astin, F., Aström-Olsson, K., Budaj, A., Clemmensen, P., Collet, J.-P., Fox, K.A., Fuat, A., Gustiene, O., Hamm, C.W., Kala, P., Lancellotti, P., Maggioni, A.P., Merkely, B., Neumann, F.-J., Piepoli, M.F., Van de Werf, F., Verheugt, F., and Wallentin, L; The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33, 2569, 2012.
3. Berk, B.C., Fujiwara, K., and Lehoux, S. ECM remodeling in hypertensive heart disease. J Clin Invest 117, 568, 2007.
4. Sun, Y., Cleutjens, J.P., Diaz-Arias, A.A., and Weber, K.T. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28, 1423, 1994.
5. Monaghan, M.,Greiser,U., Wall, J.G.,O'Brien, T., and Pandit, A. Interference: an alteRNAtive therapy following acute myocardial infarction. Trends Pharmacol Sci 33, 635, 2012.
6. Monaghan, M., and Pandit, A. RNA interference therapy via functionalized scaffolds. Adv Drug Deliv Rev 63, 197, 2011.
7. Li, Z., Hassan, M.Q., Jafferji, M., Aqeilan, R.I., Garzon, R., Croce, C.M., van Wijnen, A.J., Stein, J.L., Stein, G.S., and Lian, J.B. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 284, 15676, 2009.
8. Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., Tacke, F., Trautwein, C., and Luedde, T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209, 2011.
9. van Rooij, E., Sutherland, L.B., Thatcher, J.E., DiMaio, J.M., Naseem, R.H., Marshall, W.S., Hill, J.A., and Olson, E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Nat Acad Sci U S A 105, 13027, 2008.
10. Monaghan, M., Greiser, U., Cao, H., Wang, W., and Pandit, A. An antibody fragment functionalized dendritic PEGylated poly(2-(dimethylamino)ethyl diacrylate) as a vehicle of exogenous microRNA. Drug Deliv Transl Res 2, 406, 2012.
11. Liu, Y., Taylor, N.E., Lu, L., Usa, K., Cowley, A.W., Jr., Ferreri, N.R., Yeo, N.C., and Liang, M. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55, 974, 2010.
12. Monaghan, M., Browne, S., Schenke-Layland, K., and Pandit, A. A collagen-based scaffold delivering exogenous microrna-29B to modulate extracellular matrix remodeling. Mol Ther 22, 786, 2014.
13. Mencia Castano, I., Curtin, C.M., Shaw, G., Murphy, J.M., Duffy, G.P., and O'Brien, F.J. A novel collagennanohydroxyapatite microRNA-Activated scaffold for tissue engineering applications capable of efficient delivery of both miR-mimics and antagomiRs to human mesenchymal stem cells. J Control Release 200, 42, 2015.
14. Duan, J., Gherghe, C., Liu, D., Hamlett, E., Srikantha, L., Rodgers, L., Regan, J.N., Rojas, M., Willis, M., Leask, A., Majesky, M., and Deb, A. Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J 31, 429, 2012.
15. Monaghan, M.G., Linneweh, M., Liebscher, S., Van Handel, B., Layland, S.L., and Schenke-Layland, K. Endocardial-tomesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve development. Development 143, 473, 2016.
16. Djokic, J., Fagotto-Kaufmann, C., Bartels, R., Nelea, V., and Reinhardt, D.P. Fibulin-3,-4, and-5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem 288, 22821, 2013.
17. York, T., Kahan, L., Lake, S.P., and Gruev, V. Real-time high-resolution measurement of collagen alignment in dynamically loaded soft tissue. J Biomed Opt 19, 066011, 2014.
18. Pudlas, M., Berrio, D.A.C., Votteler, M., Koch, S., Thude, S., Walles, H., and Schenke-Layland, K. Non-contact discrimination of human bone marrow-derived mesenchymal stem cells and fibroblasts using Raman spectroscopy. Med Laser Appl 26, 119, 2011.
19. Wolman, M., and Kasten, F.H. Polarized light microscopy in the study of the molecular structure of collagen and reticulin. Histochemistry 85, 41, 1986.
20. Yu, S.Y., Tozzi, C.A., Babiarz, J., and Leppert, P.C. Collagen changes in rat cervix in pregnancy-polarized light microscopic and electron microscopic studies. Proc Soc Exp Biol Med 209, 360, 1995.
21. Hirshberg, A., Sherman, S., Buchner, A., and Dayan, D. Collagen fibres in the wall of odontogenic keratocysts: a study with picrosirius red and polarizing microscopy. J Oral Pathol Med 28, 410, 1999.
22. Brauchle, E., Knopf, A., Bauer, H., Shen, N., Linder, S., Monaghan, Michael G., Ellwanger, K., Layland, Shannon L., Brucker, Sara Y., Nsair, A., and Schenke-Layland, K. Non-invasive chamber-specific identification of cardiomyocytes in differentiating pluripotent stem cells. Stem Cell Rep 6, 188, 2016.
23. Browne, S., Monaghan, M.G., Brauchle, E., Berrio, D.C., Chantepie, S., Papy-Garcia, D., Schenke-Layland, K., and Pandit, A. Modulation of inflammation and angiogenesis and changes in ECM GAG-Activity via dual delivery of nucleic acids. Biomaterials 69, 133, 2015.
24. Votteler, M., Carvajal Berrio, D.A., Pudlas, M., Walles, H., Stock, U.A., and Schenke-Layland, K. Raman spectroscopy for the non-contact and non-destructive monitoring of collagen damage within tissues. J Biophotonics 5, 47, 2012.
25. Frushour, B.G., and Koenig, J.L. Raman scattering of collagen, gelatin, and elastin. Biopolymers 14, 379, 1975.
26. Maegdefessel, L., Azuma, J., Toh, R., Merk, D.R., Deng, A., Chin, J.T., Raaz, U., Schoelmerich, A.M., Raiesdana, A., Leeper, N.J., McConnell, M.V., Dalman, R.L., Spin, J.M., and Tsao, P.S. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 122, 497, 2012.
27. Xiao, J., Meng, X.-M., Huang, X.R., Chung, A.C.K., Feng, Y.-L., Hui, D.S.C., Yu, C.-M., Sung, J.J.Y., and Lan, H.Y. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20, 1251, 2012.
28. Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A.C.K., Yu, C.-M., and Lan, H.-Y. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-[beta]/Smad3 signaling. Mol Ther 22, 974, 2014.
29. Holmes, J.W., Nunez, J.A., and Covell, J.W. Functional implications of myocardial scar structure. Am J Physiol Heart Circ Physiol 272, H2123, 1997.
30. Movasaghi, Z., Rehman, S., and Rehman, I.U. Raman spectroscopy of biological tissues. Appl Spectrosc Rev 42, 493, 2007.
31. Zhang, P., Huang, A., Ferruzzi, J., Mecham, R.P., Starcher, B.C., Tellides, G., Humphrey, J.D., Giordano, F.J., Niklason, L.E., and Sessa, W.C. Inhibition of microRNA 29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels. Arterioscler Thromb Vasc Biol 32, 756, 2012.
32. Ungerleider, J.L., and Christman, K.L. Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress. Stem Cells Transl Med 3, 1090, 2014.
33. Inc., I.H. IK-5001 for the prevention and remodling of the ventricle and congestive heart failure after acute myocardial infarction. NCT01226563, 2010
34. Frey, N., Linke, A., Suselbeck, T., Muller-Ehmsen, J., Vermeersch, P., Schoors, D., Rosenberg, M., Bea, F., Tuvia, S., and Leor, J. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study. Circ Cardiovasc Interv 7, 806, 2014.
35. Wieland, J.A., Houchin-Ray, T.L., and Shea, L.D. Nonviral vector delivery from PEG-hyaluronic acid hydrogels. J Control Release 120, 233, 2007.
36. Jeong, C.G., Francisco, A.T., Niu, Z., Mancino, R.L., Craig, S.L., and Setton, L.A. Screening of hyaluronic acid-poly(ethylene glycol) composite hydrogels to support intervertebral disc cell biosynthesis using artificial neural network analysis. Acta Biomater 10, 3421, 2014.
37. Benjamin, L.E., Hemo, I., and Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591, 1998.
38. Chen, C.H., Wang, S.S., Wei, E.I., Chu, T.Y., and Hsieh, P.C. Hyaluronan enhances bone marrow cell therapy for myocardial repair after infarction. Mol Ther 21, 670, 2013.
39. Tang, Z.C.W., Liao, W.-Y., Tang, A.C.L., Tsai, S.-J., and Hsieh, P.C.H. The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan. Biomaterials 32, 75, 2011.